BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 20601462)

  • 1. Curcumin prevents cardiac remodeling secondary to chronic renal failure through deactivation of hypertrophic signaling in rats.
    Ghosh SS; Salloum FN; Abbate A; Krieg R; Sica DA; Gehr TW; Kukreja RC
    Am J Physiol Heart Circ Physiol; 2010 Oct; 299(4):H975-84. PubMed ID: 20601462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin ameliorates renal failure in 5/6 nephrectomized rats: role of inflammation.
    Ghosh SS; Massey HD; Krieg R; Fazelbhoy ZA; Ghosh S; Sica DA; Fakhry I; Gehr TW
    Am J Physiol Renal Physiol; 2009 May; 296(5):F1146-57. PubMed ID: 19225048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin and enalapril ameliorate renal failure by antagonizing inflammation in 5/6 nephrectomized rats: role of phospholipase and cyclooxygenase.
    Ghosh SS; Krieg R; Massey HD; Sica DA; Fakhry I; Ghosh S; Gehr TW
    Am J Physiol Renal Physiol; 2012 Feb; 302(4):F439-54. PubMed ID: 22031851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enalapril in subantihypertensive dosage attenuates kidney proliferation and functional recovery in normotensive ablation nephropathy of the rat.
    Krivosíková Z; Sebeková K; Spustová V; Lajdová I; Dzúrik R
    Physiol Res; 1999; 48(6):429-35. PubMed ID: 10783907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D receptor agonist VS-105 improves cardiac function in the presence of enalapril in 5/6 nephrectomized rats.
    Wu-Wong JR; Chen YW; Wessale JL
    Am J Physiol Renal Physiol; 2015 Feb; 308(4):F309-19. PubMed ID: 25503724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin combined with ACE inhibitor prevents heart remodeling in 5/6 nephrectomized rats independently of blood pressure and kidney function.
    Gut N; Piecha G; Aldebssi F; Schaefer S; Bekeredjian R; Schirmacher P; Ritz E; Gross-Weissmann ML
    Am J Nephrol; 2013; 38(2):124-35. PubMed ID: 23920063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].
    Ciechanowicz A
    Ann Acad Med Stetin; 1999; Suppl 52():1-93. PubMed ID: 10589103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin alleviates oxidative stress, inflammation, and renal fibrosis in remnant kidney through the Nrf2-keap1 pathway.
    Soetikno V; Sari FR; Lakshmanan AP; Arumugam S; Harima M; Suzuki K; Kawachi H; Watanabe K
    Mol Nutr Food Res; 2013 Sep; 57(9):1649-59. PubMed ID: 23174956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioprotective effect of calcineurin inhibition in an animal model of renal disease.
    Di Marco GS; Reuter S; Kentrup D; Ting L; Ting L; Grabner A; Jacobi AM; Pavenstädt H; Baba HA; Tiemann K; Brand M
    Eur Heart J; 2011 Aug; 32(15):1935-45. PubMed ID: 21138940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of candesartan cilexetil (TCV-116) and enalapril in 5/6 nephrectomized rats.
    Noda M; Fukuda R; Matsuo T; Ohta M; Nagano H; Imura Y; Nishikawa K; Shibouta Y
    Kidney Int Suppl; 1997 Dec; 63():S136-9. PubMed ID: 9407442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A combination of Chinese herbs, Astragalus membranaceus var. mongholicus and Angelica sinensis, improved renal microvascular insufficiency in 5/6 nephrectomized rats.
    Song J; Meng L; Li S; Qu L; Li X
    Vascul Pharmacol; 2009; 50(5-6):185-93. PubMed ID: 19563735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of exercise and enalapril enhances renoprotective and peripheral effects in rats with renal ablation.
    Kanazawa M; Kawamura T; Li L; Sasaki Y; Matsumoto K; Kataoka H; Ito O; Minami N; Sato T; Ootaka T; Kohzuki M
    Am J Hypertens; 2006 Jan; 19(1):80-6. PubMed ID: 16461196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic kidney disease: cardiac and renal angiotensin-converting enzyme (ACE) 2 expression in rats after subtotal nephrectomy and the effect of ACE inhibition.
    Burrell LM; Burchill L; Dean RG; Griggs K; Patel SK; Velkoska E
    Exp Physiol; 2012 Apr; 97(4):477-85. PubMed ID: 22198016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D treatment attenuates cardiac FGF23/FGFR4 signaling and hypertrophy in uremic rats.
    Leifheit-Nestler M; Grabner A; Hermann L; Richter B; Schmitz K; Fischer DC; Yanucil C; Faul C; Haffner D
    Nephrol Dial Transplant; 2017 Sep; 32(9):1493-1503. PubMed ID: 28339837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of carvedilol on pulse pressure and left ventricular hypertrophy in spontaneously hypertensive rats with adriamycin nephropathy.
    Jovanovic D; Jovovic D; Mihailovic-Stanojevic N; Miloradovic Z; Naumovic R; Dimitrijevic J; Maksic N; Djukanovic L
    Biomed Pharmacother; 2009 Sep; 63(8):571-6. PubMed ID: 19013753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction of hyperphosphatemia suppresses cardiac remodeling in uremic rats.
    Yamazaki-Nakazawa A; Mizobuchi M; Ogata H; Kumata C; Kondo F; Ono N; Koiwa F; Uda S; Kinugasa E; Akizawa T
    Clin Exp Nephrol; 2014 Feb; 18(1):56-64. PubMed ID: 23740131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with enalapril and not diltiazem ameliorated progression of chronic kidney disease in rats, and normalized renal AT1 receptor expression as measured with PET imaging.
    Ismail B; deKemp RA; Croteau E; Hadizad T; Burns KD; Beanlands RS; DaSilva JN
    PLoS One; 2017; 12(5):e0177451. PubMed ID: 28542215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quercetin Prevents In Vivo and In Vitro Myocardial Hypertrophy Through the Proteasome-GSK-3 Pathway.
    Chen K; Rekep M; Wei W; Wu Q; Xue Q; Li S; Tian J; Yi Q; Zhang G; Zhang G; Xiao Q; Luo J; Liu Y
    Cardiovasc Drugs Ther; 2018 Feb; 32(1):5-21. PubMed ID: 29435775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypericin Alleviates Chronic Kidney Disease-induced Left Ventricular Hypertrophy by Regulation of FGF23-FGFR4 Signaling Pathway.
    Liu M; Cheng L; Ye Q; Liu H; Shu C; Gao H; Liu X; Zhang X; Chen G
    J Cardiovasc Pharmacol; 2024 Jun; 83(6):588-601. PubMed ID: 38547517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term ACE inhibition confers long-term protection against target organ damage.
    Hale TM; Robertson SJ; Burns KD; deBlois D
    Hypertens Res; 2012 Jun; 35(6):604-10. PubMed ID: 22318205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.